Introduction Detection of MTC by Measuring Serum Calcitonin (CT) Detection of MTC by Measuring the RET Proto-oncogene References 1-200 References 201-495 In MEN 2 kindred 50% of the family members ...

Proto-oncogene tyrosine-protein kinase receptor Ret is a widely expressed oncogene and chromosomal rearrangements involving RET lead to fusion genes and RET kinase activation, which occur in lung ...

Nature Biotechnology - RET-oncogene-targeting drugs draw notice. ... The companies are focusing their development efforts on NSCLC patients with rare genetic alterations in the RET proto-oncogene.

Researchers conducted a population-based cohort study to estimate the prevalence of major thyroid cancer-associated syndromes.

Mutations in some exons of the RET proto-oncogene were recently observed in Hirschsprung patients. Using DNA polymorphisms and single-strand conformation polymorphism analysis for the whole coding ...

Background: Familial medullary thyroid carcinoma (FMTC) is related to germ-line mutations in the RET proto-oncogene. The mutations concern mainly cystein residues in exons 10 and 11, whereas ...

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor (GRM1) signaling, in advanced melanoma. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This ...

Targeting rearranged during transfection (RET) proto-oncogene may be an effective therapeutic strategy for acute myeloid leukemia (AML) patients with mutations in FLT3 and activated RET. However, few ...

PHILADELPHIA, Jan. 31, 2022 /PRNewswire/ -- Fusion oncogenes, such as RET- and NTRK-gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest risk of ...

Cite this: Calcitonin (CT) and RET Proto-Oncogene Measurement - Medscape - Jan 01, 2003. Introduction; Detection of MTC by Measuring Serum Calcitonin (CT) ...